Gilead price target raised to $80 from $70 at Cantor Fitzgerald

Cantor Fitzgerald raised the firm’s price target on Gilead (GILD) to $80 from $70 and keeps a Neutral rating on the shares post the Q3 report. The firm cites higher product sales continued outperformance from HIV and Veklury for the target increase.